Related Experiment Video
Updated: Jul 14, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53
Shanshan Duan1, Zhan Yao, Dezhi Hou
1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
Abstract:
Although the recently identified Pirh2 protein is known as a p53-induced ubiquitin-protein E3 ligase, which negatively regulates p53, the detailed mechanism underlying the regulation of Pirh2 remains largely unknown. Here, we demonstrate that while Pirh2 is mostly detected in the phosphorylated form in normal tissues, it is predominantly present in the unphosphorylated form in majority of tumor cell lines and tissues examined. Phosphorylated Pirh2 is far more unstable than its unphosphorylated form. We further identified that Calmodulin-dependent kinase II (CaMK II) phosphorylates Pirh2 on residues Thr-154 and Ser-155. Phosphorylation of Pirh2 appears to be regulated through cell cycle-dependent mechanism. CaMK II-mediated Pirh2 phosphorylation abrogates its E3 ligase activity toward p53. Together, our data suggest that phosphorylation of Pirh2 may act as a fine-tuning to maintain the balance of p53-Pirh2 autoregulatory feedback loop, which facilitates the tight regulation of p53 stability and tumor suppression.
Insights
Pirh2 protein phosphorylation by CaMK II regulates its E3 ligase activity, impacting p53 stability. This fine-tuning mechanism is crucial for maintaining the p53-Pirh2 feedback loop and tumor suppression.
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Biochemistry
Background:
- Pirh2 is a p53-induced ubiquitin-protein E3 ligase that negatively regulates p53.
- The precise regulatory mechanisms controlling Pirh2 activity are not fully understood.
- Understanding Pirh2 regulation is critical for comprehending p53 stability and tumor suppression.
Purpose of the Study:
- To elucidate the regulatory mechanism of Pirh2.
- To investigate the role of Pirh2 phosphorylation in its function.
- To determine how Pirh2 phosphorylation affects its interaction with p53.
Main Methods:
- Analysis of Pirh2 phosphorylation status in normal and tumor tissues/cell lines.
- Identification of the kinase responsible for Pirh2 phosphorylation (CaMK II).
- Site-directed mutagenesis to pinpoint phosphorylation sites (Thr-154, Ser-155).
- Assessment of Pirh2 E3 ligase activity following phosphorylation.
Main Results:
- Pirh2 is predominantly unphosphorylated in tumor cells/tissues, unlike normal tissues.
- Calmodulin-dependent kinase II (CaMK II) phosphorylates Pirh2 at Thr-154 and Ser-155.
- Phosphorylated Pirh2 exhibits reduced E3 ligase activity towards p53.
- Pirh2 phosphorylation is cell cycle-dependent and affects protein stability.
Conclusions:
- CaMK II-mediated phosphorylation of Pirh2 abrogates its E3 ligase activity.
- Pirh2 phosphorylation acts as a fine-tuning mechanism in the p53-Pirh2 feedback loop.
- This regulation is essential for maintaining p53 stability and tumor suppression.
Related Concept Videos
Abnormal Proliferation
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
PI3K/mTOR/AKT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
